Peptide therapy continues to evolve, with ongoing research expanding the understanding of both compounds
Lilly CEO Dave Ricks recently noted that Foundayo is not more effective than the companys injectable Zepbound, he told CNBC, but its more accessible, its easier to fit into your daily routine. In ATTAIN-1 trials, patients on the highest dose lost an average of 12.4% of their body weight over 72 weeks, compared to the 20%-plus weight loss typically seen with injectable tirzepatide
May Help Reduce Inflammation Inflammation can contribute to pain, delayed healing, and reduced mobility
A 2022 systematic review of randomized controlled trials confirms its effectiveness in improving signs of photoaging, including fine wrinkles, skin texture, and collagen formation
For this reason, it is often discussed as a peptide that may support lipolysis more directly than appetite-suppressing medications